Wolverine Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Wolverine Trading’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-151	Closed	-$2K	–	5322
2022 Q3	$2K	Buy	+151	New	+$3.9K	﹤0.01%	4488
2022 Q1	–	Sell	-419	Closed	-$17K	–	6732
2021 Q4	$17K	Sell	419 -272	-39%	-$17K	﹤0.01%	5518
2021 Q3	$46K	Buy	+691	New	+$50.6K	﹤0.01%	6031
2021 Q2	–	Sell	-617	Closed	-$40K	–	6931
2021 Q1	$40K	Buy	+617	New	+$48.1K	﹤0.01%	5696
2018 Q4	–	Sell	-494	Closed	-$121K	–	5565
2018 Q3	$121K	Buy	494 +137	+38%	+$32.4K	﹤0.01%	4470
2018 Q2	$88K	Hold	357	–	–	﹤0.01%	4769
2018 Q1	$88K	Buy	+357	New	+$93.7K	﹤0.01%	4769
2017 Q4	–	Sell	-744	Closed	-$272K	–	5657
2017 Q3	$272K	Buy	+744	New	+$264K	﹤0.01%	3400
2017 Q2	–	Sell	-536	Closed	-$159K	–	5149
2017 Q1	$159K	Buy	536 +379	+241%	+$95.6K	﹤0.01%	3659
2016 Q4	$35K	Sell	157 -107	-41%	-$21.5K	﹤0.01%	4262
2016 Q3	$60K	Buy	+264	New	+$54.9K	﹤0.01%	4365

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wolverine Trading's DMK Position: Q1 2022 in Review

Wolverine Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2022, closing a stake of 209 shares — an estimated $9K sold.

Wolverine Trading first reported a position in DMK in Q4 2016 and held it in 10 quarters. The position peaked at $195K in Q4 2017. 46 funds tracked by Wall St. Rank hold DMK as of Q1 2022.

Wolverine Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
Wolverine Trading sold 209 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2022, an estimated $9K.
Wolverine Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2016 and held it in 10 quarters.
Wolverine Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $195K in Q4 2017.
46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.